Active · per the CBE, 17 November 2026

N.P-HistoCytex

BE0861168473

Rechtspersoon Private limited company

Avenue des Evaux 1, 1341 Ottignies-Louvain-la-Neuve

Active for

23 year, 1 month

Financials

Financial year 2025

N.P-HistoCytex from Ottignies-Louvain-la-Neuve, company number BE0861168473, closed financial year 2025 with a result of € 46,433 after tax. For that financial year N.P-HistoCytex recorded a gross margin of € 97,783 and equity of € 228,629. Compared with financial year 2024, the result moved from € 29,193 to € 46,433. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 18, 2026.

What it is worth Growing

€ 228,629

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 46,433

▲ 59% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,157

▲ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 210,029.

People and assets in 2025

Vehicles and equipment

€ 27,405

▼ 7% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go

€ 19,743

▼ 32% vs 2024

€ 9,476 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes

€ 27,189

▲ 93% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 8,574 € 46,204 € 53,347 € 97,783 ▲ 83%
Profit after taxes € -2,977 € 31,512 € 29,193 € 46,433 ▲ 59%
Equity € 121,491 € 153,003 € 182,196 € 228,629 ▲ 25%
Total debts € 7,500 € 40,261 € 43,276 € 46,932 ▲ 8%
Cash € 3,976 € 15,836 € 32,978 € 47,157 ▲ 43%
Retained profit € 102,891 € 134,403 € 163,596 € 210,029 ▲ 28%
Bank debt € 7,500 € 38,695 € 29,219 € 19,743 ▼ 32%
Balance sheet total € 128,991 € 193,264 € 225,472 € 275,560 ▲ 22%

Key figures of N.P-HistoCytex, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to N.P-HistoCytex?

What happened at N.P-HistoCytex in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 46,433 (▲ 59% vs 2024). filed late Source: NBB ↗
  • Start of the company according to the CBE. KBO

In short

From € 2,977 loss in 2022 to € 46,433 profit in 2025.

Paid € 30,755 in corporate taxes since 2022.

Best year ever: 2025, with € 46,433 profit.

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue des Evaux 1

1341 Ottignies-Louvain-la-Neuve

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0861.168.473
VAT number
BE 0861.168.473
Registered office
Avenue des Evaux 1, 1341 Ottignies-Louvain-la-Neuve
Names & denominations
N.P-HistoCytex
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
17 October 2003
Peppol
Active · Active since 30 Dec 2025

Frequently asked questions

What is the address of N.P-HistoCytex?
The registered office of N.P-HistoCytex is located at Avenue des Evaux 1, 1341 Ottignies-Louvain-la-Neuve.
Is N.P-HistoCytex still active?
Yes. According to the CBE (17 November 2026) N.P-HistoCytex is active, legal situation “Normale toestand”, started on 17 October 2003.
Is N.P-HistoCytex registered on Peppol?
Yes, N.P-HistoCytex is registered on the Peppol network with ID 0208:0861168473.
What is the enterprise number of N.P-HistoCytex?
The enterprise number of N.P-HistoCytex is BE0861168473.
When was N.P-HistoCytex founded?
N.P-HistoCytex was founded on 17 October 2003.
Is N.P-HistoCytex a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 October 2003; 5 annual accounts filed, latest fiscal year 2025.